Letter to the Editor Is there a role for sequential afatinib and osimertinib in patients with EGFR mutation? Natsuhiko Iwamoto, Young Hak Kim, Shigeaki Iwatsubo, Yoshihiro Nishimura, Yasuhiro Funada
